Park Medi World Ltd (PARKHOSPS) is currently trading at 231.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Park Medi World Limited operates a 17‑hospital multi‑super‑speciality network concentrated in North India, offering tertiary and quaternary care across an expanding footprint with an emphasis on affordable, high‑quality clinical outcomes and cluster densification strategies that prioritize replication of operational protocols and clinician retention. Q1 FY27 performance showed revenue of Rs.476 crores (up 19% YoY), EBITDA of Rs.126 crores (26.5% margin) and PAT of Rs.89 crores (18.6% margin), with ARPOB at Rs.30,444 and a 12% YoY ARPOB increase; management cites substantial margin expansion driven by interest reduction, operational leverage and a targeted ARPOB growth range of 10–12% annually. The company is in an aggressive inorganic and organic expansion phase: calendar 2026 additions total 1,490 beds with three recent hospital additions commissioning November–December 2026, Rudrapur commissioned August 2, 2026, and a plan to reach 5,740 beds by FY28 funded primarily via internal accruals and IPO proceeds without meaningful fresh debt. Key structural exposures include a 77% government‑scheme payer mix in Q1 FY27 with management aiming for a 70:30 government to non‑government split within 12–18 months, while a CGHS rate revision is expected to lift ARPOB by ~7–7.5% overall but much of the incremental benefit will be partly reinvested into equipment and facility upgrades.

Over the past 52 weeks, Park Medi World Ltd has traded between a low of ₹138.15 and a high of ₹305.25. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Park Medi World Ltd has a market capitalization of approximately 9,668.77. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Park Medi World Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 32.58 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 9,668.77 Cr, Park Medi World Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Park Medi World Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Park Medi World Ltd is 32.58. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

It is a PPP mandate from Prayagraj Municipal Corporation to build and operate a 550-bed multi-speciality hospital in Prayagraj, Uttar Pradesh.

Revenue from operations rose 19% year-on-year to ₹475.7 crore, EBITDA (excluding other income) increased 20% to ₹126.1 crore, and net profit rose 35% to about ₹88.6 to ₹89.0 crore.

The stock gained as the company updated exchanges about the schedule for approving Q1FY27 unaudited results and confirmed an analyst and institutional investor call on August 4, 2026.

Park Medi World reported consolidated net profit after tax of ₹825.00 million for the quarter, compared with ₹579.00 million in the corresponding quarter last year.